Overview
CBUS market data
Price History
CBUS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.78 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.67 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -2,366.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.09 – $4.19 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $148.8M · P/B 4.33 · P/S 34.73.
Company News
Cibus shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 14, 2026, 1:23 PM
12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · Aug 14, 2026, 12:06 PM
Transcript: Cibus Q2 2026 Earnings Conference CallBenzinga · Aug 13, 2026, 9:26 PM
8-K filing — Cibus, Inc. (CBUS)SEC EDGAR · Aug 13, 2026, 8:14 PM
Cibus Q2 EPS $(0.29) Misses $(0.26) Estimate, Sales $994.000K Miss $1.704M EstimateBenzinga · Aug 13, 2026, 8:05 PM
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value CreationGlobenewswire Inc · Jun 8, 2026, 11:15 PM
Cibus Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 14, 2026, 9:15 PM
Cibus Q1 EPS $(0.33), Inline, Sales $1.681M Beat $1.616M EstimateBenzinga · May 14, 2026, 8:07 PM